9. Chisolm JJ, Brown DH. Micro scale photofluorometric determination of "free erythrocyte protoporphyrin" (protoporphyrin IX (3-7) . We undertook the present study to evaluate the effect of the unadjusted (as excreted) pH of the urine on the measurement of oxalate. During the study the subjects were eating constant diets. Their urine pH was varied by the administration of NaHCO3 or KHCO3. Results for urine collected with no pH adjustment were compared with those for specimens collected separately in acid. Each subject was observed during four control days; during four subsequent four-day periods when each subject received NaC1, KC1, NaHCO3, or KHCOS, 90 inmol/day, in divided doses with meals (the sequence of administration of the salts was varied among subjects); and during a final four-day control period. On day two or three of each of the six study periods, the subjects collected 24-h urines preserved with 20 mL of
pH. These observations reinforce recommendationsthat urine specimensfor measurementof oxalate be collectedin acid to avoid the increase in apparent oxalate content that occurs during collection of alkaline urines. This increase presumably results from the well-known in vitro nonenzymatic conversionof ascorbate to oxalate. Average prevailing urine oxalate concentrations are thus of major importance in determining calcium oxalate crystallization and stone growth (2) . Recent studies have demonstrated that urine alkalinized in vitro can support nonenzymatic conversion of urinary ascorbic acid to oxalate, thus falsely increasing the measurements of urinary oxalate concentrations and estimates of oxalate excretion rates (3) (4) (5) (6) (7) . We undertook the present study to evaluate the effect of the unadjusted (as excreted) pH of the urine on the measurement of oxalate. During the study the subjects were eating constant diets. Their urine pH was varied by the administration of NaHCO3 or KHCO3. Results for urine collected with no pH adjustment were compared with those for specimens collected separately in acid. Each subject was observed during four control days; during four subsequent four-day periods when each subject received NaC1, KC1, NaHCO3, or KHCOS, 90 inmol/day, in divided doses with meals (the sequence of administration of the salts was varied among subjects); and during a final four-day control period. On day two or three of each of the six study periods, the subjects collected 24-h urines preserved with 20 mL of 6 mol/L HC1. On day four of each period, the subjects collected 24-h urine specimens preserved with thymol and phenylmercuric nitrate and kept under a layer of mineral oil. None of the urines was refrigerated during collection. The subjects carried on their usual activities. None was given vitamin supplements.
AddItionalKeyphrases

MaterIals and Methods
With
We also reviewed measurements of urinary oxalate excretion in six-day urine pools (prepared by combining 2% of the volume of 24-h urine specimens preserved with thymol and phenylmercuric nitrate and collected under mineral oil) from four additional subjects during control conditions and during the administration of NaHCO3, 60 mmol/day, and during KHCO3, 60 mmoliday, in a previously reported study (8) .
Urinary pH was measured with a Radiometer pH meter in samples anaerobically aspirated from beneath the layer of mineral oil. Aliquots of the urine were frozen at -20#{176}C for subsequent batch analysis. Daily urine volumes were measured in graduated cylinders. Urinary oxalate concentrations were measured by the method of Hodgkinson and Williams (9). All urines from any one subject were analyzed in a single assay. Table 1 , the group mean urinary oxalate excretion rate for the six urines from each subject, collected and preserved in acid, was 271 ± 79 niolJday.
Results
As shown in
The individual mean coefficients of variation (CVs) averaged 6.4%. There were no differences in mean oxalate excretion in urines collected in acid for the group during the control periods or during administration of any of the salts, the oxalate excretion, in micromoles per day, averaging precontrol 270 ± 92, during NaCI 266 ± 73, during KC1 282 ± 72, during NaHCO3 280 ± 82, during KHCO3 256 ± 64, and post-control 273 ± 96.
Mean urinary pH averaged 5.94 for the four urines collected at the prevailing urine pH during the two control periods and during the administration of NaC1 or KC1. The mean urinary oxalate excretion rates in these urines averaged 263 ± 88 tmoIJday, a value not significantly different from the urines collected in acid. The CVs averaged 9.4%.
However, when the urine pH was experimentally increased to about 6.90 by the administration of NaHCO3 or KHCO3, apparent urinary oxalate excretion at the higher prevailing urine pH values averaged 398 ± 132 imolJday, a value significantly higher than the values observed in the urines collected in acid (P <0.025) or in the urines collected at the prevailing urine pH during control conditions and the administration of NaCl or KC1 (P <0.005). For these eight subjects, the apparent oxalate excretion rates were 47% higher during the administration of NaHCO3 or KHCO3 when the urines were collected at the prevailing urine pH than was the case for urines collected in acid.
These differences in oxalate excretion were not accounted for by variations in the accuracy of the daily urine collections, because creatinine excretion for the group averaged 15.7 ± 3.6 mmollday for the six urines collected in acid, 15.0 ± 3.4 for the four urines collected at the urine pH prevailing during the two control and the NaC1 or KC1 periods, and 15.0 ± 3.7 mmollday for the two urines collected at the urinary pH prevailing during NaHCO3 or KHCO3 administration.
Similarly, in the four additional subjects, urinary oxalate excretion averaged 382 ± 110 mol/day during the administration of NaHCO3 or KHCO3 when the urinary pH averaged 6.70, a value 43% higher than the mean value of 267±35 miolJday in these subjects when their urinary pH averaged 6.03 during control conditions ( Table 1) .
As shown in Figure 1 , urinary oxalate excretion as measured in specimens collected at the unadjusted urinary pH and expressed as a percentage of the individual mean value for the six urines collected in acid exceeded 100% of the latter value during the administration of NaHCO3 or KHCO3 and increased progressively as the urinary pH exceeded 6.5.
Moreover, as shown in Figure 2 , when the data for all 12 subjects were evaluated, the percentage increase in urinary oxalate during administration of NaHCO3 or KHCO3 above the value observed during the administration of NaC1 or KC1 and (or) control conditions was significantly related to the mean urinary pH produced during the administration of NaHCO3 or KHCO3. These percentage increases in urine oxalate in urines collected with no pH adjustment during NaHCO3 and KHCO3 administration
were not related to estimates of individual dietary ascorbic acid or oxalate contents among the subjects. Furthermore, although individual urine oxalate excretion rates during the administration of NaC1 or KC1 and (or) control conditions were correlated to body weight (Figure 3) , the percentage increases in apparent oxalate excretion during NaHCO3 or KHCO3 administra-MEANURINE pH during administration of NaHCO3and KHCO3 Fig. 2 . Individual moan daily urinary oxalate excretion rates among 12 healthyadultsduringtheadministration of NaHCO3and KHCO3, expressedas a percentageof individual meanoxalateexcretion ratesduringthe administration of NaCIor KCIand (or)duringthe control periods in relation to urinepH
The curvedline shows the mean exponential regression relationship: y = 9.8#{149} 10-#{176}. tion were not related to either basal oxalate excretion or body weight.
DiscussIon
The results of the present study confIrm, for subjects fed constant diets, previous studies demonstrating that apparent urinary oxalate excretion is falsely increased when some urine specimens are either collected at the spontaneous (and presumably alkaline) urine pH (5) or urine is experimentally alkalinized in vitro (3, 6, 7) . This effect appears to be the consequence of nonenzymatic conversion of urinary ascorbate to oxalate, because several studies have demonstrated nearly stoichiometric decrements in urinary ascorbate and increments in urinary oxalate in such alkaline urines (7) .
The careful study of Mazzachi et al. (6) demonstrated that holding the pH of the urine, to which ascorbic acid had been added to give concentrations of 1 to 15 mmol/L, at pH 5.0 or pH 6.0 had no significant effect on urinary oxalate concentrations as determined by a chromatographic technique afcer oxalate was separated from urine by precipitation with calcium chloride. By contrast, at pH 7.0, those studies demonstrated that apparent urinary oxalate concentration increased about 15% per millimole increase in urinary ascorbate. Such conversion of ascorbate to oxalate was rapid, occurring within a minute at pH 9.0. Although not tested, presumably the conversion of ascorbate to oxalate would occur more slowly at a urinary pH >6.0 but <9.0.
The method we used for determining urinary oxalate involves increasing the pH of the sample to 7.0 for the initial precipitation of oxalate with calcium. We have considered whether this brief period of alkalinization affected the results. It appears unlikely that this procedural step permits significant conversion of normal urinary ascorbate concentrations to oxalate, because measured urinary oxalate excretion rates were not different in urines collected in acid (pH s2.0) in comparison with urines collected at ambient pH in the absence of bicarbonate loading (pH -6.0). It seems more likely that the increases in urinary oxalate in urines collected at ambient pH during bicarbonate loading (pH -6.9) occurred in these more alkaline urines as the urines were being collected.
We did not experimentally vary ascorbate intake, so it may be that, when urinary ascorbate concentrations are high, as may occur among patients taking ascorbic acid, other techniques such as the addition of NaNO2 or FeC13 and Na2EDTA (7, 9, 10) would be required to prevent conversion of ascorbate to oxalate when analytical procedures require even brief alkalinization of urine samples. We have also considered our observations in relation to measurements of urinary oxalate excretion, also using the method of Hodgkinson and Williams (9), among patients with nephrolithiasis eating ad libitwn before and during the administration of potassium citrate, 60 mEq/day (11, 12). In those studies, the urinary pH averaged -6.0 before treatment and -6.7 while the subjects took potassium citrate, pH increments comparable with those observed in the present study. Despite the more alkaline urines, oxalate excretion, which averaged -350 .anoJJday, either did not change (11) or increased by only -10% (12). We have no explanation for these discrepant observations. We conclude that urines for the measurement of oxalate excretion must be collected in acid to prevent artifactual increase in urinary oxalate concentrations as a result of the in vitro nonenzymatic conversion of ascorbate to oxalate when the urinary pH exceeds 6.0. Supported in part by USPHS grants RR00058 and DK15089. We acknowledge the expert assistance of the nursing and dietary staffs of the Medical College of Wisconsin Clinical Research Center in the performance of these studies.
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